Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.
Press releases published on April 15, 2025
HYDGEN Signs MoU with Malati Fine Chemicals to Pilot Small-Scale Green Hydrogen Production in Sugar Industry
EIN Presswire
·
April 15, 2025
MANGALORE, KARNATAKA, INDIA, April 15, 2025 /EINPresswire.com/ -- HYDGEN (Hydrogen Innovation Pvt. Ltd.), a leading developer of advanced AEM electrolyzer systems, has signed a Memorandum of Understanding (MoU) with Malati Fine Chemicals (MFC), a Pune- …
Leqembi®∇ (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union
GlobeNewswire
·
April 15, 2025
In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer’s disease (early AD) who are apolipoprotein E ε4 (ApoE ε4*) non-carriers or …
71-Year-Old Sprinter and 70+ Volleyball Team Return to National Senior Games with GetSetUp Sponsorship
EIN Presswire
·
April 15, 2025
GetSetUp Athletes, Springer Madonna Hanna, and The GetSetUp Arch Rivals, Champion Active Aging as returning Sponsored Athletes at the 2025 National Senior Games MIDVALE, UT, UNITED STATES, April 15, 2025 /EINPresswire.com/ -- GetSetUp, the leading …
IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate
GlobeNewswire
·
April 15, 2025
MELBOURNE, Australia and INDIANAPOLIS, April 16, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces preliminary results from the Phase 2 IPAX-Linz study of TLX101 (131I-iodofalan1) in …
Fatima Rifai Expands Functional Diet Supplement Business Amid Lebanon’s Economic Crisis
GlobeNewswire
·
April 15, 2025
Photo Courtesy of Diet By Tam BEIRUT, Lebanon, April 15, 2025 (GLOBE NEWSWIRE) -- Diet by Tam, a health and wellness company based in Beirut, has announced the expansion of its functional supplement range with the introduction of five new products. The …
Theratechnologies Provides Update on Sale Process
GlobeNewswire
·
April 15, 2025
MONTREAL, April 15, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced that following careful consideration of the current …
Theratechnologies fait le point sur le processus de vente
GlobeNewswire
·
April 15, 2025
MONTRÉAL, 15 avr. 2025 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique au stade commercial, annonce aujourd’hui qu’après un examen attentif des circonstances …
Radiance Announces First Patient Dosing in Phase 1 Clinical Trial of its Next Generation ROR-1 Targeted ADC for Hematologic and Solid Malignancies
GlobeNewswire
·
April 15, 2025
BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc. (“Radiance” or the “Company”), a clinical stage biopharmaceutical company advancing Antibody Drug Conjugates (‘ADCs’), today announced that the first patient in China has been dosed in the …
DigiMed Healthcare Emerges as India’s Premier AI-Driven Digital Marketing Agency for Doctors and Hospitals
EIN Presswire
·
April 15, 2025
Now introducing an advanced LLM-powered chatbot assistant to revolutionize patient interaction, appointment booking, and healthcare access. NEW DELHI, DELHI, INDIA, April 15, 2025 /EINPresswire.com/ -- In an era where a patient’s first interaction with …
Ascension Seton to Take Full Ownership of Cedar Park Medical Center, Strengthening Patient-Centered Care
GlobeNewswire
·
April 15, 2025
CEDAR PARK, Texas, April 15, 2025 (GLOBE NEWSWIRE) -- Ascension Seton is deepening its commitment to patient-centered care in Central Texas by acquiring full ownership of Cedar Park Medical Center. This transition marks a significant step in Ascension …
Protara Therapeutics Announces Appointment of Leonardo Viana Nicacio, M.D., as Chief Medical Officer
GlobeNewswire
·
April 15, 2025
NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the appointment of Leonardo Viana Nicacio, M …
Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 15, 2025
SAN DIEGO, April 15, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that on April 14, 2025, non- …
Milestone Scientific Reports Year-End 2024 Financial Results and Reports Strong Outlook for 2025
GlobeNewswire
·
April 15, 2025
Reports expansion of CompuFlo® Epidural System across additional pain management clinics and ambulatory surgery centers following Medicare price assignment in multiple U.S. states ROSELAND, N.J., April 15, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific …
Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell & Gene Meeting on the Med
GlobeNewswire
·
April 15, 2025
LONDON, Ontario and BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company, today announced that the Company’s Cell Pouch Bio-hybrid Organ in clinical …
Tvardi Therapeutics Announces Closing of Merger with Cara Therapeutics
GlobeNewswire
·
April 15, 2025
Merger creates a Nasdaq-listed, clinical-stage biopharmaceutical company – Tvardi Therapeutics – developing novel treatments targeting STAT3 to treat fibrosis-driven diseases Tvardi shares to begin trading under the symbol “TVRD” on April 16, 2025 Post- …
NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board
GlobeNewswire
·
April 15, 2025
BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- NeuroNOS, a biopharmaceutical company focused on developing transformative treatments for Autism Spectrum Disorder (ASD) and Alzheimer’s disease (AD)conditions, and a subsidiary of Beyond Air (NASDAQ: XAIR), is …
Healthcare Integrated Technologies Inc. Appoints Sasidhar Valluru as Director of Global Product Delivery
GlobeNewswire
·
April 15, 2025
Mr. Valluru Joins to Strengthen HITC’s Global Technology Operations Knoxville, TN, April 15, 2025 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies Inc. (OTC PINK: HITC), a global leader in AI-driven safety and monitoring solutions, proudly announces …
Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer
GlobeNewswire
·
April 15, 2025
- Initial results from randomized Phase 2 CRDF-004 trial in RAS-mut mCRC were released in December 2024 - - Additional clinical data from CRDF-004 trial expected in 1H 2025 - SAN DIEGO, April 15, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: …
RadNet, Inc. to Acquire iCAD, Inc. to Accelerate AI-Powered Early Detection and Diagnosis of Breast Cancer
GlobeNewswire
·
April 15, 2025
The acquisition will unite complementary leading AI-powered cancer detection and workflow solutions focused on improving the accuracy and early detection of breast cancer The transaction is expected to add to RadNet’s wholly owned subsidiary, DeepHealth, …
Century Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoimmune Diseases and Cancer on Tuesday, April 22, 2025
GlobeNewswire
·
April 15, 2025
PHILADELPHIA, April 15, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in autoimmune disease and cancer, today …